| Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial AX Zhu, RS Finn, J Edeline, S Cattan, S Ogasawara, D Palmer, ... The Lancet Oncology 19 (7), 940-952, 2018 | 2108 | 2018 |
| Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ... The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017 | 2076 | 2017 |
| Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ... The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018 | 1497 | 2018 |
| Systemic inflammation in decompensated cirrhosis: characterization and role in acute‐on‐chronic liver failure J Clària, RE Stauber, MJ Coenraad, R Moreau, R Jalan, M Pavesi, ... Hepatology 64 (4), 1249-1264, 2016 | 709 | 2016 |
| Clinical course of acute‐on‐chronic liver failure syndrome and effects on prognosis T Gustot, J Fernandez, E Garcia, F Morando, P Caraceni, C Alessandria, ... Hepatology 62 (1), 243-252, 2015 | 662 | 2015 |
| Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study A Santoro, L Rimassa, I Borbath, B Daniele, S Salvagni, JL Van Laethem, ... The lancet oncology 14 (1), 55-63, 2013 | 656 | 2013 |
| Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future A Wieckowska, AJ McCullough, AE Feldstein Hepatology 46 (2), 582-589, 2007 | 587 | 2007 |
| Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre-and Post-Liver Transplantation Patients ER Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ... Hepatology 38 (6), 1419-1427, 2003 | 574 | 2003 |
| The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ... Journal of viral hepatitis 21, 34-59, 2014 | 559 | 2014 |
| ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype … P Andreone, MG Colombo, JV Enejosa, I Koksal, P Ferenci, A Maieron, ... Gastroenterology 147 (2), 359-365. e1, 2014 | 545 | 2014 |
| Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis R Loomba, M Abraham, A Unalp, L Wilson, J Lavine, E Doo, NM Bass, ... Hepatology 56 (3), 943-951, 2012 | 536 | 2012 |
| Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics N Callewaert, HV Vlierberghe, AV Hecke, W Laroy, J Delanghe, ... Nature medicine 10 (4), 429-434, 2004 | 531 | 2004 |
| Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDG I Kayani, JB Bomanji, A Groves, G Conway, S Gacinovic, T Win, J Dickson, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 529 | 2008 |
| Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 … M Manns, D Samuel, EJ Gane, D Mutimer, G McCaughan, M Buti, ... The Lancet Infectious Diseases 16 (6), 685-697, 2016 | 514 | 2016 |
| Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure A Kribben, G Gerken, S Haag, S Herget–Rosenthal, U Treichel, C Betz, ... Gastroenterology 142 (4), 782-789. e3, 2012 | 481 | 2012 |
| Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis V Nobili, F Vizzutti, U Arena, JG Abraldes, F Marra, A Pietrobattista, ... Hepatology 48 (2), 442-448, 2008 | 464 | 2008 |
| Biliary strictures following liver transplantation: past, present and preventive strategies S Sharma, A Gurakar, N Jabbour Liver Transplantation 14 (6), 759-769, 2008 | 464 | 2008 |
| Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis O Krenkel, T Puengel, O Govaere, AT Abdallah, JC Mossanen, ... Hepatology 67 (4), 1270-1283, 2018 | 462 | 2018 |
| Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection CL Lai, M Rosmawati, J Lao, H Van Vlierberghe, FH Anderson, N Thomas, ... Gastroenterology 123 (6), 1831-1838, 2002 | 459 | 2002 |
| The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota ML Balmer, E Slack, A De Gottardi, MAE Lawson, S Hapfelmeier, L Miele, ... Science translational medicine 6 (237), 237ra66-237ra66, 2014 | 454 | 2014 |
